< Back to previous page
Researcher
Peter Bossuyt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Jun 2015 → Today
Publications
11 - 20 of 155
- DEVELOPMENT OF A BELGIAN CORE SET OF QUALITY OF CARE MEASUREMENTS FOR PATIENTS WITH INFLAMMATORY BOWEL THROUGH A NATIONAL DELPHI PROCESS(2023)
Authors: Peter Bossuyt, Caroline Weltens, Marc Ferrante
Pages: S676 - S677 - CHANGE IN FATIGUE IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE INITIATING VEDOLIZUMAB OR OTHER BIOLOGIC THERAPY: DATA FROM BELGIAN REGISTRY PATIENTS(2023)
Authors: Peter Bossuyt
Pages: S751 - S751 - INTERIM RESULTS FROM THE RANDOMIZED VERDICT TRIAL TO DETERMINE THE OPTIMAL TREATMENT TARGET IN PATIENTS WITH ULCERATIVE COLITIS(2023)
Authors: Peter Bossuyt
Pages: S1107 - S1108 - NETWORK META-ANALYSIS TO EVALUATE THE COMPARATIVE EFFICACY OF INTRAVENOUS AND SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB IN THE MAINTENANCE TREATMENT OF ADULT PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS(2023)
Authors: Peter Bossuyt
Pages: S654 - S654 - I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease(2023)
Authors: Peter Bossuyt
Pages: 771 - + - Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial(2023)
Authors: Peter Bossuyt
Pages: 215 - 227 - Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF,Vedolizumab or Ustekinumab: A Real-World Multicentre European Study(2022)
Authors: João Guedelha Sabino, Peter Bossuyt
Pages: 1882 - 1892 - Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial(2022)
Authors: Marc Ferrante, Peter Bossuyt, Séverine Vermeire
Pages: 1294 - + - Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position Paper(2022)
Authors: Peter Bossuyt
- CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease(2022)
Authors: Peter Bossuyt, Séverine Vermeire
Pages: 950 - 964